Robert Peter Kadlec serves as Executive at MiNK Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Robert Peter Kadlec has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 1, 2025 involved receiving (via award) 1,218 shares valued at $13.5K.
Robert Peter Kadlec currently holds 19,126 shares of MiNK Therapeutics, Inc. (INKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Peter Kadlec has been a net neutral trader of INKT stock. They have purchased $0 and sold $0 worth of shares.
Robert Peter Kadlec's most recent insider trade was on Dec 1, 2025, when they sold 1,218 shares at $11.09 per share.
Get notified when new Form 4 filings are submitted
| $13.86 |
| Discretionary |